Table: Hisamitsu - 9-MTH group results

Hisamitsu Pharmaceutical Co

10/01/2020 06:00

Jan 10 (Reuters)- 
             Hisamitsu Pharmaceutical Co Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Nov 30, 2019        Nov 30, 2018     Feb 29, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               99.08              102.59           143.50    
                   (-3.4 pct)          (-6.9 pct)       (+0.1 pct)  
  Operating           18.42               15.95            22.90    
                   (+15.4 pct)         (-25.0 pct)      (+2.8 pct)  
  Recurring           19.92               17.41            25.50    
                   (+14.4 pct)         (-21.0 pct)      (+3.5 pct)  
  Net                 15.42               13.33            19.40    
                   (+15.7 pct)         (-15.8 pct)      (+1.0 pct)  
  EPS              187.36 yen          159.35 yen       235.72 yen  
  EPS Diluted      187.14 yen          159.20 yen                   
  Ann Div                               82.50 yen        83.00 yen  
  -Q2 div           41.50 yen           41.25 yen                   
  -Q4 div                               41.25 yen        41.50 yen  
  
  NOTE - Hisamitsu Pharmaceutical Co Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T